Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Arrowhead Pharmaceuticals (ARWR) over the last 15 years, with Q4 2025 value amounting to $277000.0.

  • Arrowhead Pharmaceuticals' Other Non Operating Income fell 1876.83% to $277000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $5.2 million, marking a year-over-year increase of 38419.04%. This contributed to the annual value of $5.3 million for FY2025, which is 40085.81% up from last year.
  • Arrowhead Pharmaceuticals' Other Non Operating Income amounted to $277000.0 in Q4 2025, which was down 1876.83% from $4.7 million recorded in Q3 2025.
  • Arrowhead Pharmaceuticals' Other Non Operating Income's 5-year high stood at $4.7 million during Q3 2025, with a 5-year trough of -$3.1 million in Q3 2024.
  • Over the past 5 years, Arrowhead Pharmaceuticals' median Other Non Operating Income value was $323500.0 (recorded in 2023), while the average stood at $350400.0.
  • Over the last 5 years, Arrowhead Pharmaceuticals' Other Non Operating Income had its largest YoY gain of 226250.0% in 2024, and its largest YoY loss of 53486.75% in 2024.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Other Non Operating Income (Quarter) stood at -$707000.0 in 2021, then surged by 171.71% to $507000.0 in 2022, then decreased by 16.96% to $421000.0 in 2023, then fell by 19.0% to $341000.0 in 2024, then decreased by 18.77% to $277000.0 in 2025.
  • Its Other Non Operating Income was $277000.0 in Q4 2025, compared to $4.7 million in Q3 2025 and -$176000.0 in Q2 2025.